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 Abstract 
One of the biggest barriers in creating large tissues is the lack of oxygen and nutrient 
transport required for cell growth and tissue development in the interior region. The post-
implantation cell survival in large tissue engineering constructs can be assisted by 
prevascularization. In this work we used a bottom-up approach to prepare large, 
prevascularized tissue constructs through perfusion culture of porous, cell-laden hydrogel 
constructs biologically assembled from smaller gel modules. The small gel modules had a 
controlled shape and were laden with HUVECs and hMSCs. They were packed in a 
bioreactor for perfusion culture, during which capillary formation inside and between 
individual gel modules led to the assembly of the small modules into a nearly centimeter 
sized porous construct. Viable cells and hollow lumen-like structures were observed 
throughout the porous construct, while in a nonporous control construct with similar 
dimensions viable cells were only observed in a peripheral layer several hundred micron 
thick. This modular assembly approach allows for creation of prevascularized large tissue 
constructs through the biological assembly of gels, which was difficult previously. 
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Chapter 1: Introduction 
1.1 Tissue Engineering 
1.1.1 Purpose of Tissue Engineering 
Tissue engineering is the combination of engineering and life sciences with the 
purpose of recreating natural cell environments or developing biological substitutes that 
can recreate, restore, or improve the function of tissues or organs 1. These biological 
substitutes can help advance medicine in several ways. First, they can be used to replace 
diseased or damaged tissue in vivo. While there has been great success in restoring 
function through organ transplantation, it can be difficult to find compatible donors, 
leading to long wait times that can result in deterioration or death of patients while 
waiting for the needed tissue to become available2,3. For example, there are over 95,000 
patients on the waiting list for an organ, and over 6,300 people die waiting for an organ to 
save their life 2. If these needed organs could be created in vitro, not only could it greatly 
reduce the number of deaths, but the organ could be made more suitable for the specific 
patient. But in addition to this use, tissue engineering constructs could also be quite 
useful for in vitro testing. The study of organs and biological systems currently relies on 
live human subjects, which have limited use for ethical reasons, animal subjects, which 
again have ethical limitations as well as limitations in similarity to human anatomy, or 
post-mortem analysis which is limited in scope. One way to ethically deepen the 
understanding of the human body and how it is effected by diseases would be to recreate 
normal or diseased systems with tissue engineering 4,5. A third important potential use of 
tissue engineering is to create platforms to test novel disease treatment methods. 
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Currently, one of the most common methods is animal testing, which has been shown to 
be a very effective as a drug screening method and resulted in many medical 
breakthroughs. But even animals with biological systems closest to humans still have 
important differences in specific signaling pathways that may be crucial for treating 
human diseases. With effective tissue engineering constructs, new drugs can be more 
easily assessed with human tissue without endangering live patients, leading to safer and 
more effective drugs and therapies 6,7. 
 
1.1.2 Current Applications 
There are several examples of medical breakthroughs resulting from progress in 
tissue engineering. One of the largest success stories is the creation of skin grafts to treat 
burns and other wounds. As far back as 1962, it was shown that a synthetic substitute for 
skin could be created 8, and in 1979, a skin substitute was actually used to treat a patient, 
leading to the first commercial skin graft product 9. Since then there have been significant 
advances not only in skin grafts but also in the replacement of damaged cartilage 10. 
Beyond commercial applications there have been significant advances that have 
culminated with the implantation of bladder11, trachea12, and bone13. There has also been 
significant progress in the development of other organ constructs such as heart valve 14, 
liver15, and pancreas16 tissue, to just name a few significant examples. The field of tissue 
engineering has shown remarkable advances in the short time it has been around, and has 
already had a huge impact on how the medical field approaches treatment 17. 
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1.1.3 Important Factors in Tissue Engineering 
While there have been significant developments in tissue engineering since its 
inception, there remain many difficulties, largely due to the complexity and 
interdependence of natural tissues.  There are many factors that are crucial to the creation 
of a tissue engineering construct that can effectively replace human tissue. First, 
mechanical properties of the construct are crucial for cell survival 17.  Different types of 
tissue require different mechanical properties - tissues such as bone require stiffer 
substrates to properly develop, while nerve regeneration benefits from a less stiff 
substrate 18,19. Even similar cell types can react differently to the same mechanical 
stimuli; it was shown that MSCs not only react to different mechanical stimulation, but 
MSCs extracted from bone react differently than MSCs extracted from hair when 
exposed to the same mechanical stimulation 20. This also leads to the conclusion that cell 
type as well as cell source are crucial in forming the desired tissue construct. Another 
very important part of designing tissue engineering constructs is the biochemical factors 
present in the construct. These can be supplied through the extracellular matrix used to 
create the construct 21, other cells present in the construct22, or soluble factors present in 
media23. The concentration, soluble versus immobilized presentation, and gradients of 
these signals are all important for cell development. For example, the peptide RGD can 
assist in cell adhesion when immobilized, while the soluble peptide inhibits cell 
spreading 24. Gradients in stathmin can effect microtubule formation 25, even to the point 
where there are measurable differences in concentration between adjacent cells 26. 
Another factor crucial for tissue engineering constructs is the porosity of the construct, as 
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the diffusion of nutrients and oxygen and removal of waste is crucial for cell survival, 
and pores also play an important role in supporting cell motility. The biological 
complexity of cells interacting with their microenvironments is what makes biological 
systems difficult to carefully design. 
 
1.1.4 Current Barriers in Tissue Engineering 
 As discussed, most biological systems require special material types and 
concentrations, specific cell types and even cell sources, and soluble factors to correctly 
form a construct. And to make this more difficult, many tissues are not homogenous 
structures, meaning that it can require different cell types, mechanical properties, and 
signaling molecules depending on both position within the structure and at different times 
as the culture progresses 27,28. But one of the largest hurdles that must be overcome is the 
limitation of nutrient and oxygen delivery to cells contained in an engineered construct. 
In vivo, this issue is solved through the circulatory system. Cells are generally only a few 
hundred microns away from a blood vessel, and the flow of blood through the vessels 
means that the diffusion distance of oxygen to any cell is only the distance to the nearest 
capillary. In order for tissue engineering constructs to mimic natural tissues, many still 
require high concentrations of cells. Without a method of circulating oxygen and 
nutrients through the system, diffusion distances are much greater, which limits most 
tissue constructs to about a millimeter in size 29. The scope of this issue can be seen by 
looking at which areas of tissue engineering have seen the most success – cartilage and 
skin. Cartilage has lower metabolic requirements, and therefore lower oxygen demand, 
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and it has even been shown that hypoxia can be an important signal to cells used for 
cartilage repair 30. The success in skin has come largely because of the thickness required 
- the epidermis of the skin is limited to thicknesses less than 100 microns 31. This layer 
has been where most of the success has originated; clinical applications of full thickness 
skin grafts have proven much more difficult to create, which impedes the treatment of 
more severe burns and wounds. To achieve the goal of engineering large complex tissues, 
we require greater ability to provide oxygen and nutrients throughout tissue engineering 
constructs. 
 
1.2 Hydrogels 
 1.2.1 Hydrogel Design 
 A critical element to engineering three-dimensional tissue constructs is the 
polymer scaffold. Initially, cell culture was performed in two-dimensional plate cultures, 
and while this proved useful for learning about cells, it is unable to recapitulate the 
structures found in a three-dimensional organism. The scaffold created by the human 
body to support cells is referred to as the extracellular matrix, and is composed of many 
different types of molecules. This scaffold provides varied microenvironments for cells to 
flourish, and must be replicated in order to make effective tissue engineering constructs.  
The primary type of material that has been shown to be effective at replicating this matrix 
is a broad category of polymers known as hydrogels.  
Hydrogels are water-swollen, cross-linked polymeric networks, composed of 
natural polymers or other polymers with similar properties 32. Different tissue engineering 
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goals have unique requirements, so there is no single type of scaffold that works best for 
all constructs. Different polymers have unique properties based on many factors:  rigidity 
of the polymer backbones, types of cross-linking molecules and cross-linking density, as 
well as gel swelling as a result of hydrophilic/hydrophobic balance 33.  These factors can 
lead to differences in the adhesion and gene expression of cells seeded within the scaffold 
34
. Depending on the application, the speed of gel formation and degradation can also be 
important. Another important factor when choosing a scaffold for a tissue engineering 
application is the biological signaling it can provide. Correct cell signaling through either 
mechanical properties or immobilization of small molecules can assist in cell adhesion, 
cell division, cell motility, cell shape, and cell differentiation 35,36. Another important 
factor is the biocompatibility of the hydrogel with the human immune system. It is 
desirable to use gels that will not trigger an immune response from the body, which can 
lead to rejection of the construct.  This leads to two broad categories of hydrogels – 
natural hydrogels, or polymers that are naturally found to compose biological tissue, 
which generally have the advantage of biocompatibility, and synthetic hydrogels, which 
tend to be less biocompatible, but more versatile and allow for finer control of 
mechanical properties and signal presentation. 
 
 1.2.2 Natural Hydrogels 
 There have been a variety of natural polymers that have proven effective for the 
creation of tissue engineering constructs. One of the most commonly used is the protein 
collagen, which can form physical gels under physiological conditions. The most 
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abundant protein in mammals, it can be degraded with cell-produced enzymes and 
contains peptide sequences that are important for cell signaling 37. It does have some 
drawbacks, such as lower mechanical strength, and batch to batch variation in 
composition, but it has been widely used in reconstructing skin38, liver39, blood vessels40, 
and small intestines41.  
 Fibrin is a natural polymer associated with the clotting of blood during wound 
healing, which leads to minimal inflammatory response when used in tissue engineering. 
It is a protein with mechanical properties similar to collagen, and also contains cell 
signaling peptides such as RGD. It is formed from the chemical cross-linking of 
fibrinogen in the presence of thrombin under normal cell conditions 42. Fibrin gels have 
been utilized to engineer tissues with cartilage 43, muscle cells 44, nerve cells45, pancreas 
46
, and blood vessels47. 
 Hyaluronate is a glycosaminoglycan (a type of polysaccharide) found in natural 
extracellular matrices, and is also an important factor in would healing. Isolation of pure 
hyaluronate has proven more difficult than other natural polymers, and it requires 
carbodiimide chemistry for cross-linking 42. It also typically possesses low mechanical 
strength, but has found uses in many areas including constructs for muscle 48, adipose49 
and skin tissues50. 
 Other commonly used natural polymers include alginate, a polysaccharide from 
brown algae that can easily gel in combination with Ca2+ ions. While it is biocompatible, 
it is severely limited by uncontrolled dissolution of the gel caused by the diffusion Ca2+ 
ions out of the gel. Because of this it has seen more use as a delivery vehicle for cells 51, 
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although modification has resulted in uses for skeletal muscle differentiation.52. Chitosan 
is another polysaccharide polymer with stronger mechanical properties and stability 
through gelation caused by chemical cross-linking. On the other hand, it is relatively 
insoluble at neutral pH, so it is more common to synthesize derivatives for use  in tissue 
engineering applications 53. It has found uses in applications including nerve and bone 
constructs 54. 
 
 1.2.3 Synthetic Hydrogels 
 As opposed to the natural polymers, synthetic polymers are more easily controlled 
and reproduced with specific molecular weights, cross-linking densities, and linkage 
degradation rates, which can give them a significant advantage in creating desired 
properties in hydrogels, but the downside is they tend to have lower biocompatibility than 
the natural polymers. One example of a commonly used synthetic hydrophobic polymer 
is Poly(ethylene  glycol) (PEG), or Poly(ethylene oxide) (PEO). The monomers can be 
easily cross-linked when modified with acrylate and exposed to UV light in the presence 
of a photoinitiator 55. It has been approved for several applications due to its low toxicity 
both during cross-linking and implantation. It has shown great promise with its 
adaptability, especially when modified with poly(lactic acid) (PLA)56 or cleavable 
peptides57 that allow for more controlled degradation, whereas the attachment of peptides 
such as RGD allow for the alteration of cell attachment properties58. It has also been 
proven effective for drug delivery, such as with the delivery of insulin or cancer 
treatments 59,60. 
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 A widely used example of a hydrophilic polymer is poly (vinyl alcohol) (PVA). It 
can be chemically cross-linked, but to reduce toxicity, it can also be physically cross-
linked using a freeze/thaw method 61. Because the freeze/thawing method can not be done 
in-vivo or in the presence of cells, and PVA hydrogels do not degrade in most 
physiological environments, it has been used as long term scaffolding for treating issues 
in cartilage and bone62,63. 
 Polypeptides are a different type of synthetic polymer – while they are 
synthesized in vitro, they are a biological product and are a crucial part of the natural 
extracellular matrix, and there has been a significant effort to design synthetic analogs of 
natural proteins as well as ones with novel function. The assembly of individual peptides 
through chemical synthesis is limited in accuracy and length, so a common production 
method uses genetically modified bacteria to express large amounts of the cloned protein 
64
. The diversity of peptide building blocks allows for significant variety in products, 
which can form anything from a silk-like protein to a reversible or physically cross-
linked hydrogel 65-67.  
 
 1.2.4 Composite Hydrogels 
 While the examples above are not comprehensive, they show the large range of 
available options when creating hydrogels for tissue engineering, and researchers have 
found that further tailoring of the constructs properties is possible by combining multiple 
types of polymers into a single scaffolding. For example, natural hydrogel compositions 
of alginate and chitosan were used to assist with cartilage function 68 and a mixture of 
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alginate, chitosan, and fibrin was used for adipose tissue engineering 69. Combinations of 
synthetic and natural polymers have also show promise, granting the ability to have better 
control of gel properties while still providing important cell signaling, such as with 
Hyaluronic acid/PEG hydrogels assisting with nerve growth70 or PVA with natural ECM 
support assisting with cartilage regeneration71. The possibilities created with the use of 
the many natural and synthetic hydrogels allow for a large range of options when 
developing tissue engineering constructs. 
 
1.3 Vascular Network Formation 
 1.3.1 Purpose of Vascularization 
 As previously mentioned, one of the biggest barriers to creating large tissue 
engineering constructs is the inability for diffusion to match the cellular requirements for 
oxygen, nutrients, and waste removal. This is largely due to the limitations of host tissue 
forming a vascular network in unvascularized implanted tissue – vascular ingrowth from 
surrounding tissue into a construct can be limited to microns per day, taking weeks to 
even reach a millimeter of ingrowth 72. And without a vascular system present to remove 
waste and supply oxygen and nutrients, constructs must rely on diffusion from the 
vascular system present initially only in the host tissue. With normal cell densities, this 
diffusion can only supply oxygen at a distance on the order of hundreds of microns, 
which limits construct depths to about a millimeter 73. In order to reduce or eliminate this 
problem, researchers have found that forming a vascular network in the construct before 
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implantation can greatly increase the rate at which the host vasculature can perfuse the 
implanted construct. 
 
 1.3.2 Cell Sources 
 The type of cell most commonly used in developing vasculature is human 
umbilical vein endothelial cells (HUVECS). HUVECs have been proven to effectively 
form vasculature in vitro, are relatively easily obtained, and can be quickly expanded in 
large numbers 74. Other types of endothelial cells (EC) can also be used, providing 
distinct advantages and disadvantages. For example, mature human EC can form 
capillary-like structures without addition of angiogenic factors, but they are limited by 
low proliferation potential, making it the difficult to obtain them in large numbers 75. 
Another available source of ECs is embryonic, induced pluripotent, or other stem cells, 
although there are ethical concerns in the case of embryonic stem cells. And while 
obtaining higher numbers is not an issue, the difficulty in controlling differentiation can 
make this a more complex task than HUVEC culture. Another promising new source for 
autologous ECs is endothelial progenitor cells, which can be found circulating in the 
blood and are more easily obtained in larger numbers compared to mature ECs, which 
allows for great proliferation potential 76.  For this study, HUVECs were used in order to 
be able to compare to the wider body of literature to inure the new culture methods lead 
to similar results when compared to more established methods. 
 While ECs alone can begin the vascularization of constructs, it has been shown 
that without support, the networks will quickly begin to regress. By supporting the ECs 
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with other cells, researchers have greatly enhanced their vascularization potential. Several 
cell types have proven to be useful in supporting vessel formation, including fibroblasts 
77
, smooth muscle cells (SMCs) 78, and mesenchymal stem cells (MSCs)79.  These cells 
assist in the formation of vasculature by stabilizing blood vessels as they form as well as 
by releasing angiogenic growth factors 80,81. While several cell types have been shown to 
be effective, in a direct comparison MSCs were found to be more effective than 
fibroblasts, which lead to their use in their project 82. Specifically, MSCs have been found 
to become intimately associated with the ECs to support the formation of tubular 
structures, and cause ECs to upregulate extracellular proteases, specifically membrane-
type matrix metalloproteinases 83,84. 
 
 1.3.3 Scaffolds 
 The most common types of hydrogels used to support the development of ECs 
into vascular networks are the polypeptides fibrin and collagen 47,75,85,86. Fibrin is 
especially promising because of its role in wound healing, which requires it to support the 
formation and repair of vasculature networks during the formation of new tissue. While 
no other hydrogel has been achieved the same success, there have been some promising 
results using other natural and hybrid gels. For example, collagen mixed with PEG has 
shown the development of defined hollow lumens 87, and fibrin ribbons encapsulated in 
PEG gels also assisted in the formation of vasculature88. Gelatin, or denatured collagen, 
that has been methylated to assist with cross-linking was also used to create a porous 
structure able to support vessel formation 89. While there are advantages to modifying 
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fibrin and collagen or using a hybrid gel, these methods have not proven to be as 
effective, and since the modifications were not needed, pure fibrin gels were used for 
prevascularization work here.  
 
 1.3.4 Current Research 
 There are three main methods people currently use to attempt to form vasculature 
networks in gels. The first involves the creation of a porous scaffold and seeding cells to 
line the pores which can then form tube structures that are easily perfused 90. But this 
method has significant limitations in both the complexity of the network and the size of 
capillaries formed, as it very difficult to effectively seed cells into small channels without 
causing blockages. The second method is the creation of vascular outgrowths from cells 
seeded on a surface. This has been attempted by seeding cells on the surface of the gel 
and allowing them to grow into the gel 91, or by seeding cells on the outer surface of 
microbeads, which are then encapsulated inside the gel and can form vascular outgrowths 
extending from the microbeads 92. These methods form better vasculature in response to 
VEGF gradients in addition to requiring support cells. The third method of creating 
vascular networks seeds the cells throughout the gel and allows the spreading and 
connection of cells to form a vascular network, and that is the method used for 
experiments here. There has been a significant amount of research explaining how these 
networks form in vitro with HUVECs and MSCs by Andrew Putnam’s group, especially 
in the area of how support cells assist in the network formation through upregulation of 
genes in EC’s to produce membrane-type matrix metalloproteinases for degradation of 
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the extracellular matrix 83,84,93. Usefulness of this method has also been demonstrated in 
vivo, showing the ability of the preformed vascular networks to anastomize once 
implanted, which greatly decreased the time required for blood to be found circulating 
within the implanted constructs85. The Tranquillo lab has show important advances in 
creation of aligned constructs with high lumen densities with the assistance of interstitial 
flow, which more closely mimics natural vasculature 47,94,95. Significant progress has 
been made in creating tissue engineered constructs containing a vascular network in order 
to increase cell viability. 
 
1.4 Perfusion Culture 
 1.4.1 Bioreactor Design 
 While a vascular network is important in vivo, it is unable to supply nutrients in 
vitro without circulation, and when cells are initially seeded, there is no structure to 
support convective flow inside the gel. Cells must be supplied with oxygen and nutrients 
through other methods until the vasculature can develop. In order to create larger 
constructs where this is possible, researchers have turned to perfusion of porous systems. 
Instead of relying on diffusion through media and then into the gel, these gels are placed 
in a system with either intermittent or continuous media flow. This convective flow can 
act in a similar manner as blood does in vivo, making the limiting factor in oxygen 
delivery the diffusion inside the gel. And with the use of sufficiently porous structures, 
the liquid is able to flow inside the construct, allowing for the creation of constructs on 
the centimeter scale that allows all cells to be within a few hundred microns of the 
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perfusing media, greatly enhancing the cell viability. One example of the advantages of a 
perfusable system used small collagen gels seeded with cells. Each gel was only a few 
hundred microns in size, but many of these gels were assembled in a larger tube. Media 
or whole blood was perfused through this tube, and cell viability remained high 
throughout all of the gels 96. Perfusion of stem cells seeded in gels resulted a 50% 
increase in cells per bead when compared to batch culture, and had the additional benefit 
of having more consistent nutrient and gene marker levels by controlling nutrient 
concentrations in the perfusing media97. Another example used mammalian cell spheroids 
and monitored cell densities. In batch culture the cell densities remained unchanged 
compared to static culture and had wide variations in glucose concentrations, while 
perfusion cultures showed significant cell density increases and an ability to regulate 
nutrient levels 98. Perfusion culture can not only increase cell viability by lowering 
diffusion distance of nutrients, it also can provide closer control over nutrient levels in 
order to allow for closer mimicry of in vivo environments. 
 
 1.4.2 Porous Scaffolds 
 One common method of creating a 3D perfusable system is to use a porous 
scaffold. Scaffolds are created from a porous matrix and seeded with cells in order to 
form a 3D construct. They have been commonly created out of synthetic polymers such 
as polyglycolic acid (PGA) and polylactic acid (PLLA) because degradation products can 
be removed by natural metabolic pathways 99,100. Many natural polymers of proteins and 
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polysaccharides have also been used, but the most common is collagen, with its many 
benefits for cell culture. 
  When making these scaffolds, the most important aspect is the creation of a 
continuous and complete pore structure so that liquid can perfuse the system. Most initial 
scaffolds were created by the separation of phases or materials, such as freeze drying 
collagen to create pores 101, washing away salt crystals entrapped in a matrix102, or 
dissolving one of two interwoven polymers 103. More recently, in order to better control 
the size and shape of pores in the scaffolds, researchers have been using computational 
topology design (CTD) and solid free-form fabrication (SFF) methods 104. With this, the 
desired matrixes can be designed on the computer and the replicated in lab. But even with 
this better control, there still remain significant issues with the use of scaffolds. The first 
is cell uniformity – it is difficult to get even cell distribution throughout a preformed 
porous construct, and this problem is exacerbated with smaller channels 105. This method 
also will only seed cells on the surface of the scaffold. Cells seeded on the surface are 
exposed to liquid flow through the pores, which can remove secreted cell factors that are 
crucial for cell development 106. It can also subject the cells to shear forces, and while in 
some cases these shear forces can assist in cell developments, other cell types, such as 
cardiac cells, can suffer significant damage from fluid flow 107.   
 
 1.4.3 Modular Assembly 
 In order to avoid the issues found in scaffolds, while still reaping the advantages 
of a perfusion culture, we look to the modular assembly of gels. With this method, cells 
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are seeded inside small gels, and the individual gels are connected to form a single larger 
construct while still maintaining gaps to form a porous structure that can facilitate the 
perfusion of media. There have been various methods used to assemble the individual gel 
modules. One method uses poly(ethylene glycol) diacrylate (PEGDA) to entrap cells and 
individual modules were gelled with UV light. The individual gels can be assembled in 
mineral oil due to their hydrophobic nature and then additional UV expose allows 
unconsumed acryl groups on the gel surfaces to react, forming a larger stable construct96. 
But methods that rely on UV cross-linking are limited by the depth of penetration of UV 
light, as cells seeded within the gels act as light scatters. And while longer or higher 
power exposure to UV light can increase the penetration depth, it can also cause damage 
to encapsulated cells. PEGDA gels have been assembled without the restriction of UV 
light penetration depth by modifying the gels to allow for a different cross-linking 
method. In this method, individual PEGDA gels were reacted with a specifically designed 
protein AC10cys. Multiple proteins were able to react with each gel through the Michael-
type addition of unreacted acrylate groups on PEGDA with the thiol on the cysteine 
residue of the protein.  The A group of the protein was able to physically associate to 
form tetramers at physiological conditions, which allowed assembly of the gels 108. While 
this method does not depend on UV light, it requires modification of gels with 
encapsulated cells, which leads to the possibility of culture conditions that may cause cell 
damage or inhibit cell development. Also, physical association can be vulnerable to 
changes in culture conditions that can interrupt the physical connections and lead to 
dissociation of modules. Additionally, both of these methods use PEGDA, which is not 
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very good at supporting vascular formation, even in hybrid gels containing collagen or 
fibrin. An example of a method with a material that does support vascularization uses 
collagen fibers to connect gel modules. A preformed collagen gel can be connected to 
other hybrid collagen mixtures through to the nucleation and growth of collagen fibers 
across the boundary 109. But while this method can be useful for connecting gels of 
different compositions, it is unable to connect multiple preformed gels, limiting the 
number of smaller modules that can be easily assembled into a single construct. 
 
 1.4.4 Current Research 
 Tissue engineering constructs require a constant supply of oxygen and nutrients 
both in vitro and in vivo. This can be accomplished through the creation of vasculature to 
assist in vivo, while perfusing the system while in vitro. One example of attempts to 
combine these methods was used to create a full thickness skin graft 110. While there was 
no perfusion through the interior of the construct, it was used around the exterior to 
control liquid height and nutrient concentrations in a bioreactor. It was effective at 
forming vasculature, but high liquid flow rates did impede the formation of vasculature 
inside the gel. A different method of prevascularization was able to use artery and vein 
explants to form a capillary network in a PDMS mold. The capillaries extended from the 
artery down channels in the PDMS and connected to the explanted vein, and this network 
was able to assist in the survival of cardiac cells seeded around the network 111. While the 
initial vascularization in this case is on a small scale, it is possible constructs could be 
brought together on a larger scale after capillary formation. Analysis of oxygen diffusion, 
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cell viability, and cell differentiation of MSC cells has been analyzed using a modular 
perfusion system, and it showed much higher oxygen concentrations and cell viability 
inside gels when perfused compared to static culture112. Another lab has also created a 
bioreactor for the study of angiogenesis, combining several larger gel modules for 
perfusion culture, and specifically looked at different circulating conditions and the effect 
on cell development 113. While there are several examples of the importance of perfusion 
culture and prevascularization, so far there has not been much progress in creating larger 
constructs using a combination of vascularization and perfusion.110 
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Chapter 2: Biological Assembly of Tissue Modules through Capillary 
Network Formation 
2.1 Introduction 
Creating functional tissue constructs is a primary goal of tissue engineering, as 
they can be used to replace lost human tissue, create better methods for drug testing, and 
serve as models for research into how human systems work 114,115. Natural tissues have 
complex, spatially defined structures that are difficult to mimic in vitro. In order to more 
accurately recapitulate these in vivo cell microenvironments, researchers have started 
using 3D tissue culture as opposed to the traditional 2D cell culture 116,117.  In order to 
form these larger constructs, approaches using bottom-up methods to integrate smaller 
gels into a single construct have been attempted. There have been a variety of methods 
investigated, including photocrosslinking Poly(ethylene glycol) diacrylate (PEGDA) gels 
under UV light or physically assembling them with oligonucleotides or proteins attached 
to PEGDA gels 108,118,119. Another method uses collagen fibers in a preformed gel as 
nucleation sites to integrate gels 109. But these methods all have limits – UV light only 
allows for cross-linking up to a certain depth due to cells scattering light; surface 
functionalization with other molecules can be complex and may result in non-optimal 
culture conditions during the modification; collagen fiber assembly cannot be used to link 
multiple preformed gels. 
  Another important part of creating tissue engineering constructs is their viability 
once implanted in vivo. One way to assist in oxygen and nutrient transfer post 
implantation is to pre-form a vascular network from Human Umbilical Vein Endothelial 
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Cells (HUVECs) and Mesenchymal Stem Cells (MSCs) in vitro 79,120. Once implanted, 
this pre-formed network can rapidly anastomize with the host vasculature, greatly 
decreasing the time it takes for blood to be found circulating inside the construct, which 
increases the overall viability cells within the construct 85.  Without this pre-formed 
network, it can take weeks to form even a millimeter of vascular ingrowth in a construct 
from surrounding tissue 72. And as many types of tissue require blood flow within several 
hundred microns to maintain viable cells, this severely limits the size of constructs that 
can be made using cells with high oxygen demands. 
Here we have developed an approach to biologically assemble individual gel 
modules into a single construct through the formation of an endothelial vasculature 
network both within and between gels. We observed that gels seeded with HUVECs and 
MSCs can form a vascular network that can bridge the interface between two adjacent 
gels, while gels seeded with only one of the two cell types or no cells easily fall apart 
after the same amount of culture time. This provides a simple method of modular 
assembly for preformed gels that does not interfere with cell growth and development.  
 
2.2 Methods 
2.2.1 Cell Culture 
 GFP-HUVECs (EssenBioscience) were maintained in EGM-2 media (Lonza) and 
MSCs (Texas A&M HSC) were maintained in αMEM media (Sigma) supplemented with 
10% fetal bovine serum (FBS) (Atlanta Biological) and 1% Penicillin/streptomycin 
(Thermo Scientific). Cells were cultured in 37˚C incubator with 5% CO2. Medium was 
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changed for GFP-HUVECs every 2 days and MSCs every 3 days. Passage 5 GFP-
HUVECs and Passage 4-5 MSCs were used in experiments 
 
2.2.2 PDMS Mold Formation 
 1.5% w/v agarose (Invitrogen) gel was sliced into rectangular blocks about 2 mm 
wide, 2 mm deep, and 3 cm long and placed in the bottom of an agarose coated 12-well 
plate. Silguard 184 elastomer base and crosslinker (PDMS) (Ellsworth Adhesives) were 
mixed at a 9:1 ratio for 2 minutes and then poured over the agarose forms to make 
channels. The PDMS solution is placed under vacuum for 40 minutes to remove air 
bubbles and then allowed to gel overnight at 37˚C. The agarose is removed and the solid 
PDMS molds are heated to 90˚C for 24 hours to finish cross-linking. Before they are used 
the molds are suspended in 5% w/v bovine serum albumin (BSA) (Fischer Scientific) for 
2 hours and then rinsed with phosphate buffered saline (PBS). The treated molds were 
placed in the bottom of a tissue culture plate and then dividers cut from a whole piece of 
PDMS, prepared in a similar manner to the molds, are inserted into the channels in order 
to create either 2 or 6 chambers within the channel. 
 
2.2.3 Gel Preparation and Culture 
 For 2 chamber experiments, fibrin gels are prepared by making a solution of 
200,000 GFP-HUVECs/mL, 80,000 MSCs/mL, and 7.5 mg/mL fibrinogen (Sigma) in 
EGM-2. Some gels were prepared with only GFP-HUVECs or only MSCs as controls, 
and 50 μL of 25 U/mL thrombin (Sigma) was added per mL of fibrin gel to all samples. 
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This solution was mixed and then pipetted into the left chamber of the mold. A fibrin gel 
without cells and with 1% of the fibrinogen replaced with Alexa Fluor 546 Conjugate 
fibrinogen (Invitrogen) in order to visualize gel boundaries was mixed in a similar 
manner and pipetted into the right chamber of the PDMS molds. Te gels were incubated 
for 5 minutes at room temperature and then 20 minutes in the incubator at 37˚C to allow 
the solutions to completely gel. Following this incubation, the PDMS divider was 
removed and the gels were pushed together, with the PDMS divider reinserted into the 
end of the channel to insure gels remained adjacent in culture.  EGM-2 medium was 
added to cover the molds and gels, and the gels were cultured in the incubator for 8 days, 
with media being changed every 2 days. Fibrin gels were prepared in a similar manner for 
the 6 chamber PDMS channels, except all gel solutions contained cells, and every other 
chamber replaced 10% of the normal fibrinogen with Alexa Fluor 546 Conjugate 
fibrinogen instead of 1%. 
  
2.2.4 Gel Staining and Imaging 
 From the 2 chamber experiments, samples containing only MSC’s were incubated 
with calcetin AM (Invitrogen) and ethidium homodimer 1(Invitrogen) for 2 hours, and 
then rinsed three times with PBS and incubated for 1 hour in fresh media, changing 
media at the half hour and manually shaking the dish every 10 minutes before imaging. 
Samples with GFP-HUVECs were imaged directly. Gels were either imaged with a ×10 
objective (N-Achroplan 0.25 NA) on a Zeiss Axiovert Observer inverted microscope 
equipped with an ApoTome (which allows 3D fluorescence imaging) or on a Zeiss LSM7 
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LIVE laser-scanning confocal microscope with a 40× Plan-Apochromat 0.95 NA 
objective. 
 
2.2.5 Gel Mechanical Testing 
 From the 6 chamber experiments, fibrin gels were removed from the PDMS 
molds and were tested for cohesion first in liquid and then by suspension in air. Gels that 
remained intact were then manually stretched with tweezers to test extension length 
before breaking into multiple pieces. Tensile tests were performed for constructs that 
could be effectively removed from the molds in a PBS bath on an Instron-Sacks Planar 
Biaxial Soft Tissue Testing System equipped with a 5 N load cell. The samples were 
stretched at a rate of 50 µm/s until the gel completely separated into 2 pieces. 
 
2.3 Results 
2.3.1 Biological Assembly of Fibrin Gel Modules 
 The ability of cells to migrate and develop across the boundary between two 
adjacent gels was tested using GFP-HUVECs, which have previously been shown to be 
effective at forming vascular networks at concentrations of fibrin from 2.5 mg/mL to 
10mg/mL with the support of MSCs. One fibrin solution was seeded with cells and gelled 
in one chamber of the PDMS mold, while another gel was formed containing 1% red 
fluorescent fibrinogen and no cells, and the two solutions were not allowed to come in 
contact until they were completely gelled (Figure 2.5.1, A). This allowed for the 
visualization of the boundary showing single cells are initially seeded in the left non-
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fluorescent gel, while the fluorescent gel is initially cell free (Figure 2.5.1, B). After 8 
days of culture in the mold, the GFP-HUVECs, with support of MSCs, have formed large 
tubule-like structures throughout the gel initially seeded with cells. These structures also 
crossed the original boundary between the two gels, and continue to migrate and form 
tubule-like structures well into the initially cell-free gel (Figure 2.5.1, C). It was also seen 
that the two gels became connected, and were able to be removed from the mold as a 
single piece.  
 
2.3.2 Endothelial Network Formation between Gel Modules 
Higher magnification images revealed the endothelial capillary networks present 
in the connected gels contained tubule-like structures having hollow spaces.  These 
structures were present in both gels and could even be seen crossing the boundary 
between the fluorescent and non-fluorescent gels (Figure 2.5.1, D). This was significantly 
different from gels seeded with only one cell type or no cells at all. Gels seeded with 
GFP-HUVECs alone had very different structures from the cultures also containing 
MSCs, as most cells remained rounded single cells and there was almost no tube-like 
structure formation (Figure 2.5.1, E). While single MSCs are able to form longer 
extensions, they do not form multi-cell tubule structures and do not contain hollow spaces 
– they are unable to pre-vascularize a construct without GFP-HUVECs (Figure 2.5.1, F) 
In both cases, very few cells migrated across the boundary, and the gels were not firmly 
connected as was seen in the samples containing both cell types. 
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2.3.3 Mechanical Properties of Assembled Constructs   
While these experiments show the ability of cells to cross between and connect 
fibrin gels, these connections were tested further to examine the strength of the assembly. 
To make sure that several gel modules could come together to form a single construct 
without additional cross-linking, smaller gels, all of which were seeded with either 
HUVECs, MSCs, or both cell types were formed in 6 chamber PDMS molds. Every other 
gel of the six contained 10% red fluorescent fibrin so there would be a visible color 
difference between gels after the gels had formed and been pushed adjacent (Figure 2.5.2, 
A). After 8 days of culture, constructs containing both cell types had formed tubule-like 
networks crossing gel boundaries, in the same manner seen in the 2 chamber gels. The 
entire construct was then completely removed from the well, and it remained a single 
piece when held aloft using a forceps (Figure 2.5.2, B). This was not the case for gels 
prepared with only GFP-HUVECs (Figure 2.5.2, C), only MSCs (Figure 2.5.2, D), or no 
cells, which when removed from wells split into smaller sections. To further test the 
strength of assembled constructs containing GFP-HUVECs and MSCs, they were 
stretched with tweezers by pulling one end of the gel while the other was held in place. 
The gels containing both cell types would elongate over 20% without breaking into 
multiple pieces, while gels with only one cell type would easily separate into individual 
modules (Figure 2.5.2, E). To test this more precisely, gels with both cell types were 
uniaxially stretched at a rate of 50 μm/s. The stress–strain relationship reveals an average 
strain to failure of 117 ± 26%, tensile strength of 2208 ± 83 Pa and Young’s modulus of 
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2548 ± 574 Pa based on three samples (Figure 2.5.2, F). Gels with only one type were 
unable to even be loaded into the testing system without breaking. 
 
2.4 Discussion  
Vascularization is critical to the survival of cells in most tissue engineering 
applications. While initial methods relied on ingrowth of blood vessels from the host 
tissue, this process is relatively slow and can lead to low cell viability in the implanted 
construct because without circulation through blood vessels, oxygen and nutrient 
transport to cells in the construct is limited by diffusion from the blood vessels in the host 
tissue121. But newer methods have greatly increased the speed at which blood begins to 
circulate inside constructs by using endothelial cells in coculture with support cells to 
form vasculature inside a construct before implantation. The vasculature can anastomize 
with the host vasculature, allowing for much faster perfusion of the construct by the hosts 
blood supply. But when forming larger constructs, adding cells that can form vasculature 
to a gel is insufficient. The limitations of oxygen diffusion will still cause the death of 
cells at the center of the construct during the in vitro culture, only allowing for the 
formation of vasculature around the exterior of the construct. This means that statically 
cultured constructs must be small enough to not exceed the limitation of this oxygen 
diffusion or else have low enough oxygen demand within the construct to not cause 
significant cell death.  
In order to make larger tissue engineering constructs, we designed a method to 
modularly assemble smaller gels with the ability to support vasculature.  Using fibrin 
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seeded with both HUVECs and MSCs, which others have shown to support the formation 
of vasculature, we were able to create gel modules that form a vascular network not only 
within the modules initially seeded with the cells, but also in adjacent modules that were 
initially cell-free. These vascular structures assisted in the assembly of the modules into a 
single construct, as shown by the inability of gels containing only one cell type to remain 
a single construct when moved. While there was some connection formed between the 
gels containing only a single cell type, likely caused by the migration of the HUVECs or 
MSCs into adjacent gels, only the gels with both cell types resulted in the formation of 
tubule-like structures and strong connections, indicating that the vascularization process 
is the reason for the strong connection between individual gel modules. The formation of 
vasculature also has the secondary benefit of assisting in anastomosis and therefore cell 
viability post implantation. The formation of an endothelial network that connects the gel 
modules holds even more promise here, as an endothelial network that extends to connect 
an entire construct is likely to be more effective for anastomosis than forming smaller 
networks inside the individual gel modules. 
Also important in assembled constructs is the strength of the assembly. Here we 
found a strain to failure of 117 ± 26%, a tensile strength of 2208 ± 83 Pa and a Young’s 
modulus of 2548 ± 574 Pa, which are comparable to pure fibrin gels 122. While the 
ultimate tensile strain was lower than values found for whole fibrin gels, the strength of 
the connection was similar, indicating that the modularly assembled gel constructs could 
be used in similar applications as a single large construct while maintaining the useful 
properties of modular assembly. 
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This method shows great promise for the modular assembly of even larger 
constructs. This modular assembly is advantageous for assembling smaller gels into a 
larger, porous construct instead of a non-porous gel. Connections between individual 
modules can be controlled to have boundaries that remain unattached to neighboring gels, 
which allows for the formation of gaps betweens gels that create a porous construct. 
Perfusion of the construct in combination with high porosity allows for a flow of media 
through the interior of the construct, which in turn will allow nutrients to be supplied by 
convection even in the center of larger porous gels, which means nutrients need only 
diffuse from the perfused media into the small gel, not from the exterior of the entire 
construct. This allows cells throughout the gel to remain viable and able to form 
endothelial networks throughout constructs on a much larger scale. If nutrient delivery 
still remains an issue because pore size is not large enough to accommodate flow, the size 
and number of the pores can be adjusted by using different shapes and sizes of fibrin gels. 
This biological assembly method also can be tested using alternate scaffold types, such as 
collagen or hybrid gels. 
Another advantage of creating a large gel through the biological assembly of gel 
modules is the ability to more carefully design the larger construct. Instead of making a 
single large gel with the same types and concentrations of cells, small gels can be seeded 
with different cell types or numbers. They can then be arrayed in desired patterns or 
layers, depending on what is required for individual applications. While here fibrin gels 
of different colors were assembled, they could contain different cells types or different 
immobilized signaling molecules to allow for the creation of a heterogeneous construct. 
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The ability to create larger prevascularized networks that not only cross the boundary 
between distinct gels, but also allow those gels to form a single cohesive construct is a 
significant step towards being able to create larger and more diverse constructs for tissue 
engineering applications. 
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2.5 Figures 
 
 
Figure 2.5.1: Endothelial network formation. (A) Fibrin gels were prepared in chambers 
and then pushed adjacent. (B) GFP–HUVECs and MSCs were seeded only in the left gel 
while the right cell-free gel contained red fluorescent fibrin. (C) After 8 days of culture, 
endothelial capillary networks formed and grew across the gel boundary between gels, 
assembling them into a single piece. (D) The networks had lumen-like structures 
containing hollow spaces (arrows) surrounded by endothelial cells in both gels and 
crossing the boundary between them.  (E,F) When only GFP–HUVECs (E) or MSCs (F) 
were seeded in the gel, no capillary network was able to form after 8 days of culture. 
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Figure 2.5.2: Robust assembly through endothelial capillary network formation. (A) Six 
fibrin gels containing cells with alternating gels containing fluorescent fibrin were gelled 
in individual chambers before being placed adjacent to each other. (B) Gels with both 
GFP–HUVECs and MSCs, which can form endothelial capillary networks, were firmly 
assembled into a single piece after 8 days of culture and could be suspended in air. (C, D) 
Gels containing only GFP–HUVECs (C) or MSCs (D) would fall apart even when 
handled carefully. (E) Constructs integrated from the gels containing both GFP–HUVECs 
and MSCs could be stretched by hand to over 20% longer than the initial length. (F) 
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Mechanical testing showed the stress–strain relationship for an integrated construct 
composed of gels containing both GFP–HUVECs and MSCs; the strain to failure was 
117 ± 26%, based on measurements of three samples. 
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Chapter 3: Perfusion Culture of Porous Tissue Engineering Constructs 
3.1 Introduction 
 Creating functional tissue engineering products for the replacement of natural 
human tissue is an important goal of tissue engineering1,115,123, but the number of 
commercial applications for tissue constructs so far has been mostly limited to thinner 
tissues or tissues with lower metabolic demands, such as skin and cartilage124. This is 
because creating most functional, clinically relevant tissues requires the creation of 
larger, 3D constructs, and a large obstacle to forming these constructs is the limited mass 
transfer of oxygen and nutrients 124,125. The concentration of oxygen and nutrients are 
critical for cell survival and development, but their transport in large constructs is limited 
to diffusion from the exterior construct surfaces 126. In order to overcome this barrier in 
vitro, 3D constructs containing pores allow for the perfusion of liquid through the interior 
of the construct, reducing the diffusion distance from the media to cells 127. One common 
method of forming these constructs in vitro is to seed cells onto preformed porous 
scaffolds 107,126,128. But this method leads to non-uniform cell distribution throughout the 
scaffold that can inhibit cell development, and the seeded cells become directly exposed 
to the perfusion media with associated shear stresses that may damage cells and can 
remove important cell secreted factors.  
These drawbacks can be eliminated through modular assembly of smaller 
hydrogel constructs seeded with cells packed into a bioreactor while leaving pores to 
facilitate perfusion with media 96. The gel modules can be uniformly seeded with cells, 
and the gel itself can protect the cells from shear stresses caused by the liquid flow. The 
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modular assembly of smaller gels into a single construct has been attempted using several 
methods including UV cross-linking and the physical assembly of gels modified with 
complementary proteins, but these methods come with limitations 108,129,130. UV light 
penetration into gels is limited in depth because cells scatter the light, and modifications 
of gels can create environments that inhibit cell growth.  
Also, in order to increase the viability of cells once implanted, it is preferable to 
form a vascular network within the construct so that the in vivo diffusion barrier can be 
more quickly eliminated by anastomosis of the pre-formed vascular network with the host 
vasculature 85.  So far the most effective gels for forming this network have been natural 
gels such as fibrin and collagen, and while there is progress in hybrid gels of PEG with 
fibrin or collagen, they are not as effective 87,88, so a modular assembly method with 
fibrin or collagen would be desirable. 
 We report a method to biologically assemble a large, porous, 3D, prevascularized 
fibrin gel construct. Fibrin gel modules seeded with Human Umbilical Vein Endothelial 
Cells (HUVECs) and Mesenchymal Stem Cells (MSCs) have shown the ability to form 
endothelial networks between individual gel modules, connecting them into a single 
prevascularized construct131. Here we use this method to create a larger gel construct by 
rationally designing small modules that can biologically assemble to form a single porous 
construct. By perfusing this construct in a controlled bioreactor, cells can be provided 
with oxygen and nutrients through convective flow inside the construct instead of relying 
on diffusion through the gel alone. In this way the entire construct can support higher 
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viable cell densities and form a vascular network in vitro, which in turn could greatly 
increase cell survival for constructs post implantation. 
 
3.2 Materials and Methods 
3.2.1 Cell Culture 
HUVECs (Lonza) and GFP-HUVECs (EssenBioscience) were maintained in 
EGM-2 media (Lonza). MSCs (Texas A&M HSC) were maintained in αMEM media 
(Sigma) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biological), 2mM l-
glutamine (Thermo Scientific), and 1% penicillin/streptomycin (Thermo Scientific). Cells 
were cultured in 37˚C incubator with 5% CO2. Medium was changed for HUVECs and 
GFP-HUVECs every 2 days and MSCs every 3 days. Passage 4-5 HUVECs, passage 5 
GFP-HUVECs and passage 4-5 MSCs were used in experiments. 
 
3.2.2 PDMS Mold Preparation 
 The desired final gel shape was initially created using 20% w/v 3.4 kDa 
poly(ethylene glycol) diacrylate (PEGDA) (Laysan-Bio) with 1% v/v of a 1.2M solution 
of 2,2-Dimethoxy-2-phenyl-acetophenone (Sigma) in 1-vinyl-2-pyrrolidinone (Sigma) as 
a photoinitiator. The PEGDA was photocrosslinked between glass slides separated by a 1 
mm glass spacer in an ELC4001 Light curing unit (Electro-Lite Corporation) for 55s 
under a photomask designed using Autocad containing cross shapes with a leg length of 
1.8 mm and a leg width of 1 mm. The resulting cross shaped PEGDA gels were then 
moved into a 12 well plate coated with a thin layer of 1.2% w/v agarose and allowed to 
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dry for 20 min at 37˚C. Silguard 184 elastomer base and crosslinker (PDMS) (Ellsworth 
Adhesives) were mixed at a 9:1 weight ratio and then poured over the PEGDA gels. This 
was placed under vacuum for 40 minutes to remove air bubbles and then allowed to gel 
overnight at 37˚C. The agarose and PEGDA were removed and the PDMS molds were 
heat treated at 140˚C for 5 days. These PDMS molds were then used as masters to create 
additional PDMS molds by filling them with excess 1.2% w/v agarose and covering with 
a glass coverslip before cooling at -20˚C for 1 min. Once the cross shaped agarose gels 
had solidified, they were moved to an agarose coated 12 well plate and used to create 
additional PDMS molds in the same manner as the original masters (Figure 3.5.1, A).  
 
3.2.3 Fibrin Gel Preparation 
The molds for fibrin gels were prepared by autoclaving the PDMS and then treating with 
plasma in a PDC-32G plasma cleaner for 5 min. They were then submerged in a 1% w/v 
solution of Pluronic F-127 (Sigma) in PBS for 1 hour and rinsed once with PBS before 
adding fibrinogen solution. The 7.5 mg/mL fibrinogen (Sigma) solution was prepared 
from a 30 mg/mL stock solution of fibrinogen in sodium chloride irrigation (Baxter) 
mixed with 2 million HUVECs (Lonza) or GFP-HUVECs/mL (Essen Bioscience) and 
400,000 MSCs/mL (Texas A&M) suspended in EGM-2 media. This was mixed well 
before 50 μL of 25 U/mL thrombin (Sigma) in sodium chloride irrigation was added per 
mL fibrinogen solution. This was again mixed thoroughly before either completely filling 
1 mm deep cross shape holes in PDMS molds with leg width of 1 mm and length of 1.8 
mm (Figure 3.5.1, B) or pipetting 2.5 mL into a 3 mL syringe to make a larger non-
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porous gel. The fibrin was allowed to gel for 5 minutes at room temp and then for 20 
minutes in the incubator. The gels were removed from PDMS molds using a tweezers and 
100 μL of gels were placed into a 12-well plate with 1 mL of EGM-2 media, which was 
changed every 2 days. Gel modules were statically cultured for 8 days and imaged with a 
2.5× objective (EC Plan-Neofluar 0.075 NA) on a Zeiss Axiovert Observer inverted 
microscope, while gels for perfusion culture were statically cultured in plates for the first 
3 days before being moved to a bioreactor. 
 
3.2.4 Bioreactor Preparation  
A media reservoir was made by drilling 3 holes into the plastic cap of a 50 mL 
glass bottle. The holes were covered with o-rings (5/64 ID) and held in place with 
adhesive (DP420, Ellsworth adhesives).  PDMS plugs to seal the top of the bioreactor 
were created by removing the plunger from a 3 mL syringe (1180300777, Covidien) and 
inserting a plastic transfer pipette. PDMS was prepared as described previously and 
gelled around the pipette in the syringe. It was then cut into hollow rings that would form 
a seal between the valve and syringe at the top of the bioreactor. Most parts of the 
bioreactor were sterilized by autoclave before use, including the peristaltic pump tubing 
(1/16 ID, AY242002 Pharmed PBT), connective tubing (1/32 ID, ACF00001 Tygon), 
cotton balls, filter paper (09-795D, Fischer Scientific), plastic pump fittings (13-876-1, 
Fischer Scientific), PDMS plug, and the reservoir. Valves (WU-30600-06, Cole Palmer) 
were sterilized by shaking in a tissue culture hood with 70% ethanol overnight, then 
washed with PBS 3 times and dried under UV light in the tissue culture hood.  
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3.2.5 Perfusion Culture 
The bioreactor was assembled by inserting a piece of cotton into 3 mL syringe 
and covering it with a layer of filter paper. This was pushed to the bottom of the syringe 
and served to hold gels in the bioreactor (Figure 3.5.2, A,C).  The peristaltic pump tubing 
was attached to connective tubing by the pump connectors, and this was used to connect a 
valve on the bottom of the bioreactor to the pump and then to the reservoir containing 30 
mL media (Figure 3.5.2, B,D). The bioreactor was filled with 2 mL EGM-2 media and 
then 2.5 mL fibrin gel statically cultured for 3 days was moved from tissue culture plates 
into the bioreactor, either as a single piece of gel or many small cross shaped gels. The 
top of the syringe was sealed with a valve inserted into the PDMS plug, and this was 
connected to the reservoir with tubing for circulating media through the bioreactor at a 
flow rate 120 μL/min using a low flow peristaltic pump (control company).  The reservoir 
lid was not tightened to allow for venting. The whole system except the pump was placed 
into a 37 ˚C incubator and then connective tubing was inserted into the reservoir and 
hooked up to a gas tank with 95% O2/5% CO2 (Fischer) which was slowly bubbled into 
the reservoir to insure sufficient oxygen was present in the media inside the reservoir. 
Medium was changed in the reservoir every 2 days for at least an additional 5 days of 
perfusion culture. 
 
3.2.6 Staining and Imaging of Assembled Construct 
Constructs were removed from the bioreactor and sliced about 3 mm from the top of the 
approximately 7 mm construct using a Vibrotome 3000. Samples containing HUVEC and 
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MSC’s were incubated with calcetin AM (Invitrogen) and ethidium homodimer 1 
(Invitrogen) for 2 hours, and then rinsed three times with PBS and incubated for 1 hour in 
fresh media, changing media at the half hour and manually shaking the dish every 10 
minutes before imaging. These stained samples or unstained samples with GFP-HUVECs  
were imaged on a Zeiss LSM7 LIVE laser-scanning confocal microscope with the 5× EC 
Plan-Neofluar 0.16 NA and 40× Plan-Apochromat 0.95 NA objectives. 
 
3.2.7 Mechanical Testing 
Tensile tests were performed for constructs in a PBS bath loaded into an Instron-
Sacks Planar Biaxial Soft Tissue Testing System equipped with 5 N load cells. The 
samples were prestressed by stretching then contracting the constructs 6 times for 10 
seconds at a rate of 55 µm/s. Samples were then stretched at a rate of 50 µm/s until they 
separated into two pieces. Strain at failure was recorded as the point at which the first 
large drop in stress without recovery occurred. 
 
3.2.8 Construct Perfusion 
To test perfusion of the porous constructs, they were prepared as previously 
described, except 1% of the fibrin was replaced with Alexa Fluor 546 Conjugate 
fibrinogen (Invitrogen). After gels had been cultured for 8 days (3 static and 5 perfusion), 
the medium was replaced with 20% w/v Bovine Serum Albumin (BSA) with 1% v/v 0.5 
um, yellow-green fluorescent carboxylate-modified Fluospheres (Invitrogen). This 
suspension was circulated through the perfusion system for 5 minutes at room 
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temperature and then 200 mM TCEP was combined with the BSA suspension at a 1:2 
ratio in order to break disulfide bonds in BSA. After 10 minutes of additional circulation, 
the fibrin construct in BSA suspension was moved to a 37 ˚C incubator to allow the BSA 
to gel. After the BSA had gelled, the construct was removed from the bioreactor and 
placed into a solution of 10% neutral buffered formalin (Sigma) for 5 days before being 
sectioned on a Leica CM 1900 cryosectioner and then imaged on the confocal 
microscope. 
 
3.2.9 Viability Assay 
Three sets of assembled and non-porous 2.5 mL fibrin constructs cultured under 
the same conditions were removed from perfusion culture and sliced into sections less 
than 1 mm thick by hand and then each slice was further cut into quarters. Assembled 
construct pieces were evenly distributed between 6 wells of a 6-well plate, while non-
porous construct pieces were evenly distributed between 4 wells, with 2 mL media added 
to each well. A standard curve from cells seeded on a plate and two types controls 
(freshly prepared fibrin gels seeded with cells and cell-seeded fibrin gels statically 
cultured for 8 days) were used. The standard curve of 7,000 to 224,000 cells was created 
in triplicate using freshly seeded HUVECs and MSCs at a 5:1 ratio in a 96-well plate and 
incubated for 40 minutes in 120 μL media before use. Two sets of freshly prepared cell-
laden fibrin gels with volumes of 50 or 120 μL were made as individual cross-shaped 
fibrin gel modules and as single non-porous fibrin gels (50 μL gels were cast in 96-well 
plates and 120 μL gels cast in 48-well plates). After the gels had formed they were moved 
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into 6-well plates with 12 μL of media added per μL of fibrin gel. The four types of fibrin 
gels were also prepared in the same way in duplicate and statically cultured in 12 well 
plates with 1 mL media changed every 2 days for 8 days before being moved to 6 well 
plates and adding media at the same ratio. For all samples, AlamarBlue reagent (Sigma) 
was added at 10% of the media volume. All samples were incubated for 2 hours at 37˚C 
with gentle shaking. 100 μL of the liquid from each sample was moved to a black-lined 
96-well plate, and the florescence was read with a Synergy HT Multi-Detection 
Microplate Reader (Bio-Tek) with 530ex/590em filters. 
 
3.3 Results 
3.3.1 Controlled Gel Preparation 
 We created small, cross shaped microgels that can be assembled into a larger 
porous construct in a perfusion culture system. In order to decrease the packing density of 
these gels in the bioreactor, the gels were cast in the shape of a cross (Figure 3.5.1, A).  
The maximum size of gel modules was determined by finding that HUVECs and MSCs 
could survive and form tube-like structures could form up to 600 μm deep in a non-
porous gel; therefore each gel was made to be no more than 1 mm thick to limit the 
longest diffusion distance from surface to center at 500 μm. Gels seeded with HUVECs 
and MSCs undergo significant changes in size and shape when removed from PDMS 
molds, so the gels were monitored in static culture for 8 days. It was found that gels in the 
shape of a cross made in molds with a depth of 1 mm and a leg length of 1.8 mm and 
width of 1 mm would best maintain their initial shape for the duration of the 8 day culture 
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while being easily removed (Figure 3.5.1, B), as longer legs were difficult to remove 
from a mold without breaking. As the thickness of each gel was less than 1 mm, the 
distance from the top or bottom to the center of the gel would be under 500 μm. During 
the first three days, in which the majority of the shrinking occurred, the distance from the 
vertex of the cross legs to the center of the construct from went from 800 μm to 600 μm, 
and the gels still maintained most of the initial cross shape over this time period (Figure 
3.5.1, C-D). This shrinking continued and after an additional 5 days of static culture that 
distance shrank from 600 μm to 550 μm, still maintaining some of the initial cross shape 
(Figure 3.5.1, E).  
 
 
3.3.2 Construct Assembly and Mechanical Properties 
 In order to limit the amount of channeling and increase porosity in the perfusion 
cultures, gels were maintained in static culture conditions for 3 days before moving into 
the bioreactor for perfusion culture. After 5 additional days in perfusion culture for a total 
culture time of 8 days, the gels had assembled to form a large construct that could be 
removed from the bioreactor as a single piece (Figure 3.5.3, A). This was only seen when 
the cells were viable – constructs with gels that did not contain viable cells would break 
into smaller pieces as it was removed from the bioreactor. In order to test this further, the 
constructs were uniaxially stretched, and from three samples it was found that they would 
reach strains of 72 ±18% before they would begin to tear apart (Figure 3.5.3, B-C). It was 
found that even after the construct had begun to tear (noted by a drop in force by the 
  44 
force transducers), or even after complete separation into two pieces, individual gel 
modules still remained a part of the larger construct (Figure 3.5.3, D). 
 
3.3.3 Cell Viability in Assembled Construct 
 In order to compare our construct of biologically assembled gels to a non-porous 
gel, 2.5 mL of fibrin gel precursor containing HUVECs and MSCs was cast either as 
small gels in PDMS molds or as a single gel in a 3 mL bioreactor, then cultured for 8 
days – 3 days in a tissue culture dish and then perfused with EGM-2 media in a 
bioreactor for an additional 5 days. The samples were sliced with a vibrotome and images 
of cross-sections at the top and near the center of the approximately 7 mm gels were 
taken to visualize cells survival throughout the sample. Live/dead staining revealed that 
in non-porous gel constructs, cells were viable at the top and exterior of the gels cast in 3 
mL syringes (Figure 3.5.4, A), but cells were only viable within a distance of about 600 
μm from the outer surface where the gel was in contact with media (Figure 3.5.4, C). On 
the other hand, when the construct was composed of biologically assembled fibrin gel 
modules, cells were viable through the center of constructs with diameters and heights 
over 7 mm, and were similar to cells present in the exterior of the constructs (Figure 
3.5.4, B,D), indicating nutrient transport throughout the assembled constructs and not just 
around its exterior.  To verify that the cells in the center of the construct were viable and 
tube-like structures were developing in a similar manner to static culture, GFP-HUVECs 
with MSCs were used to visualize tube formation.  After 10 days of culture (3 static and 7 
perfusion), GFP-HUVEC cells were viable throughout the center and exterior of the gel 
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(Figure 3.5.5, A,D). Images acquired at higher magnification indicated that tube-like 
structures formed at the center of cross-sections taken from the middle of the construct 
(Figure 3.5.5, B). These tube-like structures appeared to be similar in size and structure to 
those seen at the exterior of a non-porous construct and throughout statically cultured gel 
modules.  
We expected that this difference in tube-like structure formation was the result of 
an increase in porosity in the biologically assembled construct, and designed a method to 
show the perfusion of the construct. In order to visualize gel boundaries with the 
fluorescent microscope, fibrin gels were prepared with 1% of the normal fibrin replaced 
with fluorescent fibrin before being cultured for 3 days in static culture and 5 days in 
perfusion culture. The porous construct was the perfused with a solution of BSA 
containing green microbeads unable to penetrate the gels. TCEP was used to reduce 
disulfide bonds within the BSA and allowed the perfusion liquid to form gel by forming 
intramolecular disulfide bonds between BSA molecules. Sectioning of the resulting solid 
showed the presence of significant amounts of gelled BSA inside slices 3 mm below the 
top of the construct, indicating perfusion of the construct by liquid flowing through the 
bioreactor (Figure 3.5.5, C). This explains higher viability in assembled constructs, as the 
perfusion leads to lower diffusion distances between the media and cells than that in a 
non-porous gel.  
We then used the AlamarBlue reagent to quantitatively compare cell viability 
between non-porous constructs and assembled constructs as well as statically cultured gel 
modules. A linear standard curve for the AlamarBlue signal was created with 7,000 to 
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224,000 cells incubated in 120 μL of media with an additional 10% AlamarBlue for 2 
hours.  The viability ratio of cells inside freshly prepared gels to 2D cultures was found to 
be 96 ± 2% for 50 μL single gels, 103 ± 17% for 50 μL of gel modules, 92 ± 5% for 120 
μL single gels, and 93 ± 3% for 120 μL of gel modules. These results showed very 
similar values for cell viability when comparing freshly prepared 2D and 3D cultures. 3D 
gels statically cultured for 8 days resulted in consistent but significantly lower cell 
viability at 47 ± 6% for 50 μL single gels, 44 ± 8% for 50 μL of gel modules, 45 ± 6% for 
120 μL single gels, and 40 ± 4% for 120 μL of gel modules. The cells in gels statically 
cultured for 8 days on average had only 44% viability compared to freshly prepared 
samples, which could have several causes including changes in cell metabolism of 
AlamarBlue as they form capillary tubules, shrinking of the gels possibly leading to 
exclusion of cells from the gel, and some cell death (although at 8 days few dead cells 
were seen during staining). Analysis of perfused constructs after 8 days of culture 
revealed lower cell viability, as the cells in perfused porous constructs had only 30 ± 3%  
viability compared to the 2D standard curve or 68% viability compared to individual gel 
modules statically cultured 8 days. This is likely a result of both some cell death from 
incomplete perfusion and cell loss as liquid flowed through the bioreactor. But the 
constructs made of biologically assembled gels showed a much higher viability than non-
porous fibrin constructs, as non-porous constructs had only 13± 4% of the 2D standard 
curve or 31% of the viability of gel modules statically cultured for 8 days. Overall, the 
cells in non-porous constructs had less than half the cell viability of the cells in 
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biologically assembled constructs, indicating greatly improved oxygen and nutrient 
delivery in the porous construct (Figure 3.5.5, E). 
 
3.4 Discussion 
 In recent years there have been many advances in the development of 3D tissue 
engineering constructs, but there still remain barriers to their effective implementation. 
One of the most important issues in this area is the viability of cells seeded in larger 
constructs, which is greatly influenced by availability of oxygen and nutrients. In vivo, 
convective blood flow in microvasculature reduces the required diffusion distance, but in 
a large, non-porous, statically cultured hydrogel the only transport process is diffusion, 
which is insufficient to allow for cell viability for most tissues on a scale larger than a 
few hundred microns 132. The most effective method of reducing this problem for 
constructs to be implanted in vivo is to create a microvascular network inside the 
construct pre-implantation 87, 88,133. It has been shown that a prevascularized construct can 
anastomize with host blood vessels to greatly enhance the speed at which an implanted 
construct can be perfused with blood from the host, which increases the survival rate of 
cells within the implant85,134,135. Increasing in vitro viability on the other hand has been 
focused on perfusion of porous constructs, with convective flow reducing the required 
diffusion distance and therefore increasing cell viability inside the construct 96. By 
modularly assembling gels seeded with cells instead of adding cells to a preformed 
scaffold, cells can be uniformly seeded and are not exposed to shear stresses, which can 
impede cell growth and development107,108,128. So by combining modular assembly for in 
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vitro culture with vascularization strategies that improve in vivo culture, we form the 
basis for creating larger tissue engineering constructs with high cell viability. 
We have been able to create a large construct containing an endothelial network 
through the biological assembly of smaller fibrin gels, a method that uses natural cell 
development and migration to form connections between gel modules 131.  This method 
of gel assembly is not limited by the depth of UV light penetration, an issue that arises in 
the assembly of PEGDA gels. It does not require modification of the hydrogel which can 
expose cells to non-optimal conditions and interfere with cell viability and vascular 
development. It also does not rely on synthetic hydrogels, which can make vascular 
network formation more difficult. But while fibrin has been shown to be effective at 
supporting vascular formation, it does undergo significant change in shape and size when 
seeded with HUVECs and MSCs 86,134. In order to maintain pores within the final 
construct that allow for perfusion as the gels change shape, the gels had to be carefully 
designed. As we saw in non-porous constructs, capillary tubule formation is limited to 
600 μm from the surface of the tissue construct, so we designed small gels that limited 
the distance of any encapsulated cell to media to about 550 μm. In order to maintain the 
porosity of the final construct with these gels, we used high concentrations of fibrin to 
reduce shape change while still supporting vascular development, and additionally used 
fibrin gels in the shape of a cross to decrease the packing density once placed in perfusion 
culture 108. We also delayed assembling the gel modules until after most of the gel 
shrinking had occurred, which should increase the porosity of the final construct and 
reduce the channeling of the liquid around the outside of the construct. 
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After 5 days of perfusion culture the individual gel modules formed a single 
connected construct, with the gel modules remaining connected even when the construct 
was sectioned through the center for imaging or stretched uniaxially, indicating biological 
assembly occurred effectively throughout the entire construct. On the other hand if 
insufficient oxygen was supplied to the reservoir during perfusion, there was limited cell 
viability and the gels would not form a single construct, but instead broke into individual 
modules when moved, indicating it is the cells themselves that allow for the construct 
formation. So therefore this construct cohesion can only be explained by the perfusion of 
the gel, as non-porous gels with no interior media flow had cell viability limited to 600 
μm from the exterior surface, while the assembled constructs had viable cells forming 
lumen-like structures over 3 mm from the outer surface of the construct. This perfusion 
was also shown by the presence of green microbeads in the center of crossections of the 
porous construct after only 15 minutes of circulation. As seen in the Alamar-blue assay, 
the viability in the porous constructs is over twice as high as the viability of the cells in a 
non-porous construct, indicating much better delivery of oxygen and nutrients. As the 
porous constructs only had 69% of the cell viability when compared to statically cultured 
cells, the construct may benefit from additional porosity, but this could also be explained 
by fluid flow removing small pieces of fibrin from the construct, which lowers the 
volume available for cell growth. But because of the dependence on cells to assemble the 
gels, as long as the construct allows sufficient delivery of oxygen for tube-like structures 
formation this method can be scaled to create much larger constructs.  
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 This new method for creating porous constructs is an effective means of creating 
larger constructs with greatly increased cell viability. Instead of being limited to hundreds 
of microns, constructs with uniform cell viability can be created on centimeter and larger 
scale as the diffusion of oxygen and nutrients is not the limiting factor if the porosity of 
the construct is maintained. This method also allows for other possibilities, such as the 
creation of heterogonous constructs by creating unique tissue modules seeded with 
different cell types or signaling factors.  Individual modules could even initially be 
allowed to assemble in static culture on a smaller scale and then later assembled into 
separate layers or areas inside a bioreactor when forming a final construct in order to 
create defined spatial heterogeneity. Biological assembly should prove to be an effective 
method for creating large constructs that overcome oxygen limitations currently present 
in both in vitro and in vivo culture. 
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3.5 Figures 
 
Figure 3.5.1: Preparation of shaped fibrin gels. (A) The schematic shows the process of 
making molds for casting fibrin gels. PEGDA crosses are used to make PDMS master 
molds. The original PDMS molds are then filled with agarose that can be used to more 
quickly make additional PDMS molds. (B) Each cross shape is 1 mm deep and has four 
legs, each with a length of 1.8 mm and width of 1.0 mm. (C) Fibrin gels cast in these 
molds are removed as a cross shape. (D,E) The gels shrink, but still maintain some of the 
initial shape over 3 (D) and 8 (E) days of static culture.
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Figure 3.5.2: Perfusion bioreactor setup. (A) The schematic shows cotton and filter paper 
are packed into the bottom of a syringe and connected to a valve and tubing to hold fibrin 
gels in place, while the top valve is sealed in the syringe with a ring of PDMS. (B) The 
bioreactor is then connected to a reservoir containing media through tubing and a 
peristaltic pump, while the reservoir is also connected to a flow of oxygen. (C,D) Actual 
bioreactor and reservoir setup is also shown. 
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Figure 3.5.3: Mechanical stability of constructs. (A) After 3 days of static culture and 5 
days of perfusion culture, the porous construct can be removed as a single piece from the 
bioreactor. (B-C) These constructs were loaded into an Instron-Sacks Planar Biaxial Soft 
Tissue Testing System (B) and stretched uniaxially (C). (D) The constructs were 
stretched until a noticeable drop in stress occurred, reaching strains of 72 ±18 without  
constructs breaking into individual modules even as the construct was pulled into two 
pieces. 
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Figure 3.5.4: Live/dead staining of constructs. (A,C) Staining shows that after 3 days of 
static culture and 5 days culture in a 3 mL bioreactor, MSCs and HUVECs are alive at the 
exterior of a non-porous gels (A), but the viability is limited to about 600 μm from the 
exterior (C). (B,D) On the other hand, a biologically assembled construct cultured in a 3 
mL bioreactor showed good cell viability on the top (B) and throughout a slice about 3 
mm from the top of the approximately 7 mm construct (D). 
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Figure 3.5.5: Tube-like structure formation, porosity, and viability in constructs. (A, D) 
GFP-HUVECs showed similar development at the top (A) and throughout a slice about 3 
mm from the top (D) of an assembled construct after 10 days of culture. (B) The center of 
the slice contained connected cells with lumen–like structures (arrows). (C) Perfusion of 
red fibrin gels with green microbeads showed significant porosity at the center of the 
construct. (E) The cell viability in perfused porous constructs is over twice as high as that 
in non-porous constructs based on the AlamarBlue assay. The values are normalized to 
the average viability of cells statically cultured for 8 days in all four types of individual 
fibrin gels (50 and 120 μL gel modules and single gels).
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Chapter 4: Hyaluronic Hydrogels cross-linked with self-assembling  
  polypeptides 
4.1 Introduction 
Hydrogels have been widely used to assist in the differentiation, growth, and 
expansion of cells in tissue engineering. These gels generally attempt to mimic the 
extracellular matrix naturally found in vivo. Both two-dimensional (2D) and three-
dimensional (3D) hydrogels have been created using either proteins or polysaccharides, 
but there has been much less study of the benefits to using both types of polymers to form 
a single hydrogel 136-138. Polysaccharides with attached proteins, called glycoproteins, are 
a natural part of the extracellular matrix.  One example of a polysaccharide naturally 
modified by proteins is hyaluronic acid (HA), a gylcosoaminoglycan, which is a part of 
the extracellular matrix in cartilage, skin, and brain. It is important support for cell 
attachment, growth, nourishment, and migration 139. It plays a critical role in wound 
healing, immune system regulation, and nerve regeneration 140.  
Proteins are commonly attached to hyaluronic acid, and they assist in cell support 
and can also provide cell signaling 141. In the brain, hyaluronic acid binds to several 
proteins including versican, aggrecan and the glial HA-binding protein, and their 
appearance during development causes significant changes in the extracellular space 142. 
Studies of natural polypeptides found in the extracellular matrix, such as fibrin and 
collagen, have shown that small peptide sequences, such as RGD and IKVAV, are crucial 
for cell growth and differentiation 143. Through cloning and protein expression these 
peptides can be isolated and inserted into synthetic proteins. The ability to create these 
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synthetic polypeptides has proven useful, as they allow for the creation of unique 
hydrogels, and also provide a higher degree of control over gel properties 108,144.  
Here we have created a hydrogel by modifying hyaluronic acid with a synthetic 
polypeptide that can physically associate into tetramers, which allows for the creation of 
a physical hydrogel. As physical hydrogels can reversibly form and disassemble, they do 
not require degradation of the hydrogel to allow for cell mobility. This combination 
provides a way to more closely mimic the natural glycoproteins found in the extracellular 
matrix, allows for mimicry of physical stabilized microenvironments, and also can 
present peptide cellular signals such as RGD. Here we show hydrogels can support cell 
spreading in two dimensions as well as the three-dimensional cell development, such as 
cyst formation and neurite outgrowth, specifically because of the incorporation of the 
RGD sequence in the protein crosslinker. 
 
4.2 Methods 
 
4.2.1 Thiolated Hyaluronic Acid Synthesis 
Thiolated HA derivative was synthesized and characterized according to a procedure 
reported previously 145,146 and first prepared and analyzed in our lab by Bo Liu. In 
summary for a basis of 1 mL, 10 mg Hyaluronic acid (HA, sodium salt, MW 234 KDa) 
(Lifecore Biomedical Co) was reacted in water with 12 mg 3,3’-dithiobis(propanoic 
hydrazide)(DTPH) prepared from 3,3’-dithiodipropionic acid. This was done at room 
temperature for 20 minutes at a pH of 7.0. The pH was adjusted to 4.7 before adding 9.6 
mg EDC (1-Ethyl-3-[3-(dimethy-lamino)propyl]carbodiimide) to the solution, which was 
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stirred for 10 minutes. The pH was increased to 8.5 and 50 mg dithiolthreitol was added 
and the solution was stirred for 24 hours. The pH was adjusted to 3.5 and the solution 
was dialyzed against 100 mM NaCl at pH 3.5 for 4 days and then against pH 3.5 water 
for 1 day before lyophilizing to get HA-SH as a white solid that is stored at -20 ˚C under 
nitrogen. The structure and degree of substitution of HA-SH were detected by 1H NMR 
and free thiol groups on the side chain of HA-SH were measured by the Ellman (DTNB) 
method with the assistance of Bo Liu. The calculated degree of substitution for thiolated 
HA in this study was 42% and the free thiol content per 100 disaccharide units was 32%. 
 
4.2.2 Synthesis and Purification of Polypeptides 
 The genes encoding the polypeptides AC10cys and AC10RGDcys, were each 
constructed in the Qiagen pQE9 vector (Figure 4.5.1, B), In these proteins, A is a 
tetramer forming leucine zipper domain, C10 is a hydrophilic random coil, RGD is a cell-
signaling peptide and cys is a cysteine residue. The polypeptides were expressed in the 
E.coli strain SG13009 according to a procedure reported previously 147. Briefly, E. coli 
containing the desired vector was grown at 37 ˚C in 2xYT media until an optical density 
of 600 nm was reached. Protein expression was induced with 1 mM Isopropyl-b-D-
thiogalactopyranoside (IPTG, EMD Chemicals, Inc) and then incubated for an additional 
4 h. Cells were harvested by centrifugation and lysed in 8M urea (Sigma). The cell lysate 
was centrifuged and cell debris was removed. The supernatant was reduced with 2-
mercaptoethanol (0.1% V/V, Sigma) and the protein was purified through nickel-
nitrilotriacetic acid (Ni-NTA) metal-affinity chromatography, dialyzed, and lyophilized 
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to give a white powder. The polypeptides were examined by matrix-assisted laser 
desorption/ionization (MALDI) mass spectrometry and SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). 
 
4.2.3 Preparation of Polypeptide-DEGDA Conjugates 
The polypeptides previously synthesized were conjugated with di(ethylene glycol) 
diacrylate (DEGDA) through the Michael-type addition reaction. A 0.5 mM solution of 
AC10cys or AC10RGDcys was prepared in 8 M urea containing 2 mM TCEP at pH 4.5 
to break disulfide bonds.  The solution was stirred at room temperature for 1 h and the pH 
of the solution was adjusted to 8.0. DEGDA was added to the polypeptide solution at a 
50:1 molar ratio (DEGDA/polypeptide), and the mixture was stirred in the dark at room 
temperature for 12 h. The sample was dialyzed against deionized water at 4 °C to remove 
unreacted DEGDA and then lyophilized to remove water, resulting in a white powder. 
 
4.2.4 Cell Culture 
Madin-Darby Canine Kidney Epithelial (MDCK) Cells (ATCC) were cultured in 
Eagle’s Minimum Essential Medium (EMEM) (ATCC) supplemented with 10% fetal 
bovine serum FBS and 1% Penicillin/streptomycin. Cells were cultured in 37˚C incubator 
with 5% CO2 and medium was changed every 2 days. Embryonic day 7 (E7) chicken 
eggs (Generous gift from Paul Letourneau) were dissected and the dorsal root ganglia 
(DRG) were placed in F-12 media supplemented with 2mM L-glutamine, 16μM B27, 
160μM sodium pyruvate, and 8mM glucose buffered to pH 7.4 with 10 mM HEPES for a 
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short time until placed into hydrogels. Chick DRGs were cultured in hydrogels 
containing the same media with the addition of 40ng/mL NGF and 4μg/mL laminin 
148,149
. 
 
4.2.5 Preparation of Hydrogels and Cell Seeding 
To prepare hydrogels, solutions of 1.5% w/v thiolated HA and 6% w/v 
polypeptide-DEGDA (AC10RGD-DEGDA or AC10-DEGDA) or 10 kDa PEGDA (Laysan 
Bio) were made at pH 7.4 in the medium of the cells to be cultured in that hydrogel. For 
2D MDCK cultures, these stock solutions were mixed with additional media to make 
solutions with 0.4 to 1.0% w/v HA-SH and 1.4% to 2.0% w/v protein or PEGDA and the 
pH was checked to be at 7.4 to allow solid gel formation. MDCK cells were detached 
from culture flasks using 0.05% trypsin, centrifuged, and resuspended in media. After an 
hour for the hydrogel to solidify, 6,000 MDCK cells in 100 uL media were seeded on top 
of the 100 μL hydrogel in a 96 well plate and cultured for 3 days, changing media every 
other day. For 3D MDCK cultures 15,000 cells in media were combined with stock 
solutions to prepare 100 μL of gel with desired HA-SH and protein concentrations. After 
gels had set for an hour, 100 μL of medium was added on top of the gel, and the MDCK 
cells were cultured for up to 10 days, changing media every other day. Similarly for 
DRGs, 150 μL hydrogel solutions prepared with F-12 media for DRG culture were 
pipetted into a 48-well plate. The explanted DRGs were completely submerged in the 
hydrogel solution, and the solution was then allowed to gel. After 24 hours, 150 μL of 
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medium was added and the gels were incubated for 2 days and then imaged for axon 
extension from the DRG. 
 
4.2.6 Cell Staining and Imaging 
Gels containing MDCK cells were stained at a 1:1 ratio with 0.1 mg/mL Hoechst 
33342 (Thermo Fischer) in PBS for 20 minutes in the tissue culture incubator and then 
rinsed with PBS in order to visualize nuclei. All gels were imaged on a Zeiss Axiovert 
Observer inverted microscope equipped with ApoTome (which allows 3D fluorescence 
imaging) using the 10X (N-Achroplan 0.25 NA), or 20X (LD Acroplan 0.4 NA) 
objectives. 
 
4.3 Results 
4.3.1 Hydrogel Preparation 
The first step in preparing the glycoprotein system was to create a method to attach 
proteins to a polysaccharide backbone, and for this we chose to use HA, a naturally 
occurring polysaccharide.  In order to attach desired proteins to this polysaccharide the 
carboxylic acid groups on the backbone were reacted with DTPH to present thiol groups. 
Of the carboxyl groups available on the HA, 42% were converted to thiols, with 32 free 
thiols per 100 disaccharide units, as some reacted to form disulfide bonds. In order to 
allow for physical hydrogel formation, HA-SH was reacted with the proteins AC10cys 
and AC10RGDcys.  In these proteins, the A groups are leucine zippers that have the 
ability to physically associate into tetramers, allowing for physical cross-linking and 
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hydrogel formation 147. Once the proteins were produced, they were modified with 
DEGDA through Michael-type addition reaction of the thiol present in the cysteine 
residue with only one acryl group on DEGDA by having a large excess of DEGDA. The 
other acryl group on protein-DEGDA could then be attached to the thiol of HA-SH 
through a similar reaction, and so a solution of the two was able to form a physically-
assosiated glycoprotein hydrogel at neutral pH (Figure 4.5.1, A). It was observed that for 
a wide range of concentrations for both AC10-DEGDA and AC10RGD-DEGDA (1.0% 
to 2.2% w/v) with modified polysaccharide (0.4% to 1.5% w/v) the solution would form 
a solid gel within twenty minutes, capable of holding its shape without flowing. Gels 
composed of HA-SH without the protein would flow even after 24 hours, indicating that 
the attached physically-associating protein groups were required for the formation of the 
solid hydrogel. 
 
4.3.2 Cell Adhesion on 2D Hydrogels 
  To test the ability of the hydrogels to support cell growth and present the RGD 
signaling peptide, MDCK cells were seeded on top of hydrogels composed of 1% w/v 
HA-SH and 1.6% w/v protein or PEGDA and cultured for 3 days in order to observe cell 
spreading in 2D culture. The hydrogels prepared with AC10RGD-DEGDA crosslinker 
were able to support 2D growth quite well.  The cells quickly spread and covered the 
entire surface of the hydrogel (Figure 4.5.2, A). Significantly different results were seen 
when a crosslinker without the signaling peptide RGD was used - gel prepared at the 
same concentrations with the protein AC10-DEGDA, which lacks the RGD peptide, did 
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not support cell spreading on the surface of the gel. Instead cells formed a single cluster 
which shrank as cells lifted and died (Figure 4.5.2, B). This cell response was also seen in 
HA gels chemically cross-linked with PEGDA, which also lacks the RGD peptide 
(Figure 4.5.2, C). 
 
4.3.3 Epithelial Cyst Development and Neurite Extension in 3D Hydrogels 
 Gels were also tested for the ability to support epithelial cyst formation in 3D 
cultures. MDCK cells initially were seeded inside hydrogels with the same concentrations 
(1.0% HA-SH and 1.6% AC10RGD-DEGDA, AC10-DEGDA, or PEGDA) previously 
tested with 2D cultures, but there was not any significant difference between the samples. 
By testing 0.5% - 1.0% HA-SH and 1.6 -2.0% Ac10RGD-DEGDA, it was found that 
lower HA concentrations but higher protein concentrations allowed for the formation of 
large aggregates, specifically with 0.8% HA-SH and 2.0% AC10RGD-DEGDA. These 
gels allowed for formation of large, spherical structures after 6 days of culture (Figure 
4.5.3, A). This was further analyzed using the Apotome microscope feature to look at 
crossections of the spherical structures. Crossections at the top and bottom of the sphere 
showed complete cell sheets, while crossections closer the center of the sphere reveal a 
circular ring of cells (Figure 4.5.3, B,C). This indicates the cells formed a hollow sphere, 
or cyst-like structure. Higher HA-SH concentration (1.0%) resulted in smaller cell 
aggregates instead of large cyst-like structures (Figure 4.5.3, D). In hydrogels containing 
0.8% HA-SH and 2.0% AC10-DEGDA (lacking RGD), smaller cell aggregates also 
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formed, but they are more irregularly shaped and crossections through the center of the 
aggregates did not reveal any hollow centers (Figure 4.5.3, E,F). 
HA and either protein or PEGDA crosslinkers were also tested for creating 
hydrogels that support chick DRG neurite extension. Lower concentrations of both HA-
SH (0.4%) and AC10RGD-DEGDA (1.4%) proved effective at assisting in the extension 
of neurites from the explanted DRGs (Figure 4.5.4, A). Again, the presence of RGD was 
crucial as gels with 1.4% AC10-DEGDA or PEGDA had much lower levels of neurite 
extension from the DRG’s when compared to gel made with AC10RGD-DEGDA (Figure 
4.5.4, B-C). Also, the importance of gel stiffness was seen as higher concentrations of 
AC10RGD-DEGDA, specifically 1.8% or 2.2%, resulted in much lower amounts of 
neurite extension when compared to 1.4 or 1.6% (Figure 4.5.4, D-F). 
 
4.4 Discussion 
There are numerous types of hydrogels that are currently used for tissue engineering 
applications. Some are based on polysaccharides, such as chitosan and alginate gels, 
which have been shown to be useful in creation of scaffolds and microbeads for cell 
encapsulation 150-152. Others are protein based, and can be naturally occurring, such as 
fibrin and collagen, or synthetically prepared for a specific purpose, and have been shown 
provide important signals to cells 153. Here we attempt to create a hydrogel that can 
effectively integrate both polysaccharides and synthetic proteins into a single 
glycoprotein hydrogel through physical associations within the protein. We decided to 
mimic the naturally occurring extracellular matrix material HA, as it is naturally modified 
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with proteins in vivo. Using this polysaccharide backbone and synthetically prepared 
proteins would give the system a very versatile structure useful for many applications.  
Another advantage of the system we developed is the physical connections that 
create the hydrogel. Most currently used hydrogels are chemically cross-linked, creating 
junctions that must be cleaved before cells can migrate within the gel. This cleavage can 
cause material degradation within the gel and lead to undesirable changes in the 
mechanical properties of the gel. The ability to create physically cross-linked gels is also 
a way to more closely mimic some natural biological systems to assist in cell 
development. For example, the ability of basement membrane to support the rapid 
migration of leukocytes are the result of physically stabilized bonds 154.  
 We also have demonstrated the importance of signaling that can be supplied by 
synthetic peptides. Removal of the RGD peptide did not appear to influence the physical 
structure or mechanical properties of the gel, but cells reacted very differently. In two 
dimensions, they were unable to attach effectively to the gel surface; while in three 
dimensions they showed no development of cysts from MDCK cells and limited neurite 
extensions form DRGs when compared to proteins containing the RGD peptide. And 
RGD is just one example - other small peptides such as IKVAV and YIGSR have been 
shown to provide crucial signals to cells. Because of the independent preparation of HA 
and proteins, these or other signals can be provided through cloning of the peptide 
sequence. By creating multiple peptide-DEGDA molecules with unique signals , multiple 
peptides could be presented within the hydrogel. The ability to control the signaling from 
the protein in the hydrogel gives this hybrid gel great flexibility in possible applications. 
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And while signaling to cells through the RGD ligand proved to be very important, 
the concentrations of polymers, and thus mechanical properties of the gel, was also 
crucial for creating the correct environment for cells. Higher crosslinker concentrations of 
AC10RGD-DEGDA up to 2.2% w/v significantly impeded the outgrowth of neurons 
from the clusters of DRG implanted inside the gel when compared to 1.4% w/v. And 
while higher concentrations of HA-SH and protein (0.8% w/v and 2.0% w/v respectively) 
were used to support the formation of cysts compared to neurites, even higher HA-SH 
concentrations (1.0% w/v) impeded cell motility and cyst formation. This hydrogel has 
shown significant flexibility in mechanically properties to support different cell structure 
formation. 
By combining polysaccharides and polypeptides, we have created a physically 
cross-linked hydrogel that supports cells by mimicking the glycoproteins of the 
extracellular matrix. Through the use of modified hyaluronic acid and recombinant 
proteins gels at conditions commonly used in cell culture, this hydrogel can effectively 
support cell culture in both two and three-dimensional gels. It also provides important 
signaling through small peptide sequences in the protein, which can be easily adapted for 
the expression of other signaling molecules. This novel hydrogel system can support cell 
culture through signals presentation, physical crosslinking, and controlled mechanical 
properties. 
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4.5 Figures 
 
 
Figure 4.5.1: Illustration of hydrogel formation. (A) AC10RGDcys is reacted with 
DEGDA and can form tetramers by physical cross-linking. The acryl groups on the 
protein can react with thiol modified hyaluronic acid to form a physically stabilized gel. 
(B) Sequences of proteins used are presented indicating the important domains. 
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Figure 4.5.2: Effects of crosslinker on 2D MDCK spreading. (A) Solutions of 1.0% w/v 
HA-SH with 1.6% w/v concentrations of AC10RGD-DEGDA allowed for MDCK cells 
to spread.  (B,C) Samples with the same concentration of AC10-DEGDA (B) and 
PEGDA (C) show that without the RGD peptide, cells clump and detach form the gel 
surface. 
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Figure 4.5.3: Effect of HA-SH and crosslinker on 3D MDCK cyst formation. (A) MDCK 
cells in gels composed of 0.8% w/v HA and 2.0% w/v AC10RGD-DEGDA formed large 
cell aggregates over 6 days of culture, as seen with an overlay of bright field and 
fluorescent 20X images after staining with Hoechst 33342. (B, C) Images of the same gel 
using a 10X objective and Apotome to create a z-stack of 29 images separated by 4.76 
μm showed a spherical aggregate (B), while a single image at the center of the stack 
reveals a cell-free center (C), indicating cyst formation. (D) When concentration of HA-
SH was increased to 1.0% w/v without changing protein concentration, large hollow 
structures were absent.  (E, F) Cells encapsulated in 0.8% w/v HA-SH gels with 2.0% 
w/v AC10-DEGDA (lacking RGD) form smaller aggregates, and when a z-stack of 28 
images (E) was analyzed, single slices did not show any large cell-free cavities (F). 
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Figure 4.5.4: Effects of crosslinker on neurite extension. (A) Solutions of 0.4% w/v HA-
SH with 1.4%  w/v AC10RGD-DEGDA allowed for significant neurite extension from 
chick DRG’s. (B, C) Samples containing AC10-DEGDA (B) or PEGDA (C) had greatly 
decreased extension of neurites. (D-F) Mechanical properties of the gel also proved 
important, as increasing the concentration of AC10RGD-DEGDA to 1.6% (D), 1.8% (E) 
or 2.2% w/v (F) results in significantly less neurite outgrowth in chick DRG’s as the 
protein concentration increases. 
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Chapter 5: Conclusions and Future Directions 
5.1 Conclusions 
5.1.1 Biological Assembly of Tissue Modules through the Formation of 
Endothelial Networks 
Individual fibrin gels were modularly assembled though the development of an 
endothelial network. Cells seeded in a single gel were able to migrate across the interface 
into an adjacent, initially cell-free gel, and after 8 days of culture an endothelial network 
that crossed the interfaces had assisted in connecting the modules. This assembled 
construct behaved as a cohesive unit and could be manipulated without loss of individual 
modules. Both GFP-HUVECs and MSCs were crucial for this assembly, as either cell 
type alone did not develop an endothelial network and resulted in a weak construct that 
would easily break apart. Constructs assembled from 6 gels could be stretched to over 
twice their original length before breaking, and in general had similar mechanical 
properties to a whole fibrin gel, indicating a very strong connection was formed between 
individual modules through network formation. The experiments shown here are an 
important first step in using modular assembly to create porous, 3D hydrogels that can 
support cell growth throughout the construct by reducing the limitations of oxygen and 
nutrient diffusion. 
 
5.1.2 Perfusable Construct Formation through Biological Assembly 
 Large, porous constructs were assembled from smaller fibrin modules containing 
HUVEC and MSC cells. Cells initially seeded in small, cross shaped fibrin gels were 
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used to biologically assemble the individual modules into a single construct when 
cultured in a perfusion bioreactor. This single, cohesive piece of gel could be removed 
from the bioreactor and stretched over half of its initial length without loss of individual 
modules from the construct.  While cells in non-porous fibrin gels only survived and 
formed vascular structures up to 600 um from the edge of the construct, the cells in the 
biologically assembled construct proved to be viable over 3 mm from the exterior of the 
gel and showed the ability to form hollow, tube-like structures even at the very center of 
the porous gel. This is a strong indication that medium was able to perfuse the construct, 
further shown by the ability of BSA containing green microbeads to flow through the 
interior of the construct. This perfusion reduces oxygen diffusion distances, and results in 
cells being twice as viable in the porous, modularly assembled constructs compared to 
nonporous gels. The increased viability and development of a capillary network indicate 
that this method is an effective way to create larger tissue engineering constructs without 
the need for more complicated and less effective methods of modular assembly. This 
biologically assembled, porous, vascularized construct is an effective way to reduce 
barriers to cell survival and development present in larger tissue engineering constructs. 
 
5.1.3 Cell Development in Synthetic Glycoprotein Hydrogels 
By combining polysaccharides and synthetic polypeptides, we have created a 
physically associated hydrogel that supports cells by mimicking the glycoproteins of the 
extracellular matrix. The specific use of tetramer forming polypeptide A domains allows 
for the formation of this physically connected gel. The mixture of modified hyaluronic 
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acid and recombinant proteins gels can effectively support both cell spreading on top of 
the gel as well as the development of cell structures such as cysts and neurite extension 
for cells seeded inside the gel. The synthetic polypeptides used also have shown the 
ability to provide important signaling to the cells through the addition of the RGD 
peptide. This novel hydrogel system shows promise for use in a wide range of tissue 
engineering applications because it combines signaling control through the use of 
modified HA and a synthetic peptide that can be adapted to express important cell 
signaling peptides with mechanical control from physical cross-linking and wide gelation 
concentrations. 
 
5.2 Future Direction 
 While this biological assembly method showed significant promise in the 
development of large, perfusable, prevascularized constructs, there are still challenges to 
overcome, but also opportunities for new developments. In order to create specific types 
of tissues, additional cells would need to be seeded in gels, which can change oxygen 
demand. As there was already some loss of cell viability from gel modules when creating 
the larger construct, closer analysis of the shape, size, and culture time of gel modules 
may be needed in order to further optimize the perfusion of the construct after the 
addition of other cell types. Biological mechanisms were able to assemble gel modules 
after three days of static culture, but it is possible that this mechanism for connecting gels 
could be just as effective even after longer static incubation times. As there was still some 
shape and size change in gels after 3 days, it may be easier to control porosity of 
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constructs if even longer static culture times were attempted before assembly. Also, in 
order to more completely understand the uses of this method, implanting the construct 
and comparing in vivo angiogenesis to constructs without preformed vasculature would 
be useful. 
 
5.2.1 Creating Larger Tissue Engineering Constructs 
This assembly method could lead to in vivo assembly of gel modules, which 
would be beneficial from the standpoint of not having to deliver a single, large construct, 
but instead smaller gels that could possibly be injected to form the desired structure. But 
even if the biological assembly is limited to the initial stages of vascular formation, this 
method should still be able to create larger constructs. One of the main limitations is the 
difficulty in forming the many small gel modules, so improving the method of fibrin 
gelation would make assembling larger constructs easier. There have been methods for 
quickly removing gels from PDMS molds that have worked with larger gels, so it is 
possible that with some adaptation, the gel preparation can be simplified for the creation 
of the smaller fibrin modules 155. Assembly of larger constructs in a larger bioreactor 
would need to be careful of excess channeling caused by gel shrinking, but as long as the 
gel porosity can be maintained it should still be an effective method on a larger scale.  
 
5.2.2 Creating Heterogeneous Tissue Engineering Constructs 
Another opportunity arises through the controlled assembly of the individual gel 
molecules. Most tissues are very complex, and can require different cell types, cell 
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signals, or mechanical properties. This spatial control can be mimicked through the 
controlled assembly of individual tissue modules – each module can be created with 
different cell concentrations, cell types, or statically cultured with different signaling 
molecules. The module themselves can be gelled with different concentrations of 
polymer to change mechanical properties, or if effective hybrid hydrogels are found with 
the ability to support vasculature, modules can even be created from different types of 
polymers. Individual modules cultured in different conditions can then be assembled into 
heterogeneous constructs. One option would be to first assemble small numbers of these 
gels to develop small constructs before further assembling these small constructs into a 
single larger construct. Another method could use more careful construction of the 
construct, possibly with the assistance of a dissolvable barrier to seed unique individual 
gels into desired patterns within a heterogeneous construct. 
 
5.2.3 Alternate Proteins for Cell Development in Glycoprotein Gels 
 While RGD was found to be successful at supporting two-dimensional 
spreading as well as cyst formation in MDCK cells and neurite extension in chick 
DRG’s, there are many other proteins or peptides that could be tested with this type of 
hydrogel. For example, collagen or fibrin could be used in conjunction with HA to create 
an environment that could be more effective at forming prevascularized gels. Alternately, 
synthetic proteins with different or even multiple signaling peptides could be used. An 
example of this method would be to add a mixture of modified AC10 protein with 
another synthetic protein B containing a different cell signaling peptide. As the A and B 
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proteins can form a physically linked dimmer, this could allow for colocalization of 
different signals, such as α5β1 and α6β1 integrins which have been proven to be 
important in stem cell differentiation when spatial proximity is controlled 156. In order to 
make the gel more closely mimic the natural cell environment, proteins that mimic the 
function of versican, aggrecan or the glial HA-binding protein, could be used to change 
cell behavior within the gel 142. The adaptability of synthetic polymers leaves great 
potential for creating effective tissue engineering hydrogels. 
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